Psychedelics appear to be here to stay. Yet stocks, shares and finance are another story. On August 4, publicly traded clinical-stage psychedelics firm Mind Medicine Inc.
Elon Musk may not be like the conventional corporate executives, the Tesla, Inc. (NASDAQ: TSLA) CEO suggested in the "Full Send" podcast, which premiered late Thursday.
Stride, Inc. (NYSE:LRN)—a leading provider of innovative, high-quality, and tech-enabled education solutions— announced that its Board of Directors has elected Dr. Craig R. Barrett as Chairman of the Board.
Bio-Teche Corporation (NASDAQ:TECH) today announced Chuck Kummeth's planned two-year transition from his position as Bio-Techne's Chief Executive Officer (CEO) effective June 30, 2024. The
MicroStrategy Inc. (NASDAQ: MSTR) announced a CEO transition after the company posted a $1 billion loss on Tuesday night. Although founder Michael Saylor is exit